BSEAGM/EGM4d ago · 28 Aug 2026, 09:10 pm
Notice of AGM to be held on 21st September 2026 at 3:00 p.m.
Arvaya Healthcare Ltd · 524723
✦ AI SummaryMgmt Change
Arvaya Healthcare Ltd has announced the 41st Annual General Meeting (AGM) to be held on September 21, 2026, through video conferencing. The meeting will consider the audited standalone and consolidated financial statements for the financial year ended March 31, 2026, and the reappointment of Kaushal Uttam Shah as Managing Director. Additionally, the meeting will consider approval for material related party transactions.
Analysis Scores
Earnings Impact5/10
Growth Catalyst3/10
Governance Concern2/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Arvaya Healthcare Ltd - 524723 - Notice 41St Annual General Meeting
Attachments (1)
📄pdf
Download →
f14841d6-ca76-414d-b932-0492d2fdc575.pdf
View document text
Date:28th August 2026
BSE Limited
Phiroze Jeejeebhoy Towers,
Dalal Street,
Mumbai – 400 001
Respected Authorities,
Sub: Notice of Forty First Annual General Meeting
Ref: “Arvaya Healthcare Limited” (ARVAYA/524723)
Pursuant to Regulation 34(1) of the SEBI (Listing Obligations and Disclosure Requirements)
Regulations, 2015 and further to our communication dated 27th August 2026 intimating about the
Forty First Annual General Meeting (‘AGM’) of the Company, we are enclosing herewith Notice of Forty
First AGM for the Financial Year 2025-26, to be held on Monday, 21 September 2026 at 3:00 P.M. (IST)
through Video Conferencing.
The Notice of the AGM is also available on the Company’s website and can be accessed at
www.arvayahealth.com
The above is for your information and records please.
Thanking you,
For Arvaya Healthcare Limited
(formerly known as Bijoy Hans Limited)
Kaushal Uttam Shah
Managing Director
DIN:02175130
Date:28th August 2026
Place: Sangli
NOTICE
NOTICE IS HEREBY GIVEN THAT THE 41ST ANNUAL GENERAL MEETING OF ARVAYA HEALTHCARE
LIMITED (FORMNERLY KNOWN AS BIJOY HANS LIMITED) WILL BE HELD ON MONDAY, SEPTEMBER
21, 2026 AT 03:00 PM THROUGH VIDEO CONFERENCING (‘VC)/OTHER AUDIO-VISUAL MEANS
(‘OAVM’) FACILITY TO TRANSACT THE FOLLOWING BUSINESSES:
ORDINARY BUSINESS:
1. To receive, consider and adopt the Audited Standalone Financial Statements of the Company for
the financial year ended 31 March 2026, and the reports of the Board of Directors and Auditors
thereon.
To receive, consider and adopt the audited standalone financial statements of the company for the
financial year ended 31 March 2026, together with the report of Board of Directors and Auditors
thereon as an Ordinary Resolution
2. To receive, consider and adopt the Audited Consolidated Financial Statements of the Company
for the financial year ended 31 March 2026, and the reports of the Auditors thereon.
To receive, consider and adopt the audited consolidated financial statements of the company for the
financial year ended 31 March 2026, together with the report of Board of Directors and Auditors
thereon as an Ordinary Resolution
3. To consider appointment of Mr. Kaushal Uttam Shah (DIN: 02175130) Managing Director of the
company, who retires by rotation and, being eligible, offers himself for re-appointment.
To consider and if thought fit, to pass with or without modification(s) the following Resolution as an
Ordinary Resolution:
“RESOLVED THAT pursuant to the provisions of Section 152 and all other applicable provisions, if any,
of the Companies Act, 2013 read with the Rules made thereunder and as per Articles of Association ,
Mr. Kaushal Uttam Shah (DIN:02175130), Managing Director, who holds the longest tenure and retires
by rotation at this meeting, being eligible for reappointment, has confirmed his eligibility and
willingness to accept the office, be and is hereby reappointed at the same position to hold the office
for the existing tenure based on the same terms of appointment as already approved by the Members
at the 40th Annual General Meeting of the Company.
RESOLVED FURTHER THAT the Board of Directors be and is hereby authorized to do all such acts,
deeds, matters and things as may be considered necessary, desirable and expedient for giving effect
to this resolution and/or otherwise considered by them to be in the best interest of the Company
including fixation of their remuneration and reimbursement of out-of-pocket expenses incurred in
connection hereto.”
SPECIAL BUSINESS:
ITEM NO. 4 - APPROVAL FOR MATERIAL RELATED PARTY TRANSACTION (S) UNDER SECTION 188 OF
THE COMPANIES ACT, 2013 AND REGULATION 23 OF THE SEBI (LISTING OBLIGATIONS AND
DISCLOSURE REQUIREMENTS), 2015:
To consider and if thought fit, to pass, with or without modification(s), the following resolution as an
Ordinary Resolution:
“RESOLVED THAT pursuant to the provisions of Section 188 and other applicable provisions of the
Companies Act, 2013 (“the Act”) read with the rules framed thereunder (including any statutory
amendment(s) or re-enactment(s) thereof, for the time being in force, if any), and in terms of
Regulation 23 of the Securities and Exchange Board of India (Listing Obligations and Disclosure
Requirements) Regulations, 2015 (“SEBI Listing Regulations”), as amended from time to time, the
Company’s policy on Related Party Transactions, and subject to such other approvals, consent(s),
permission(s) and sanctions of other authorities as may be necessary from time to time basis the
approval and based on the recommendation of Audit Committee and the Board of Directors of the
Company (hereinafter referred to as “Board” which term shall be deemed to include the Audit
Committee of the Company and any duly constituted/ to be constituted Committee of Directors
thereof to exercise its powers including powers conferred under this resolution), the consent of the
Members of the Company be and is hereby accorded to the Board for entering into and / or carrying
out Material Related Transaction(s)/ contracts / arrangements or modification(s), alteration or
amendments of earlier/ arrangements/transactions or as fresh and independent transaction(s) or
otherwise (whether individually or series of transaction(s) taken together or otherwise), with
following, a related party failing within the definition of “Related Party” under Section 2(76) of the Act
and Regulation 2(1)(zb) of the SEBI Listing Regulations, during the financial year 2026-2027 and shall
be valid up to the date of next AGM on such material terms and conditions as detailed in the
explanatory statement annexed to this notice and as may be mutually agreed between related party
and the Company, notwithstanding the fact that the aggregate value of all these transaction(s),
whether undertaken directly by the Company or along with its subsidiary(ies), does not exceed value
as detailed in the explanatory statement provided that the said
Transaction(s)/Contract(s)/Arrangement(s)/Agreement(s) shall be carried out in the ordinary course
of business and at arm’s length basis;
Sr. Name of the Relationship Nature of Transaction Financial Year
No. Related Party Transaction Amount in
1. Agri One India Promoter of As per Section 188 40 Crore 2026-2027
Ventures LLP the Company. and RPT policy of the
Company
2. UG Patwardhan Promoter of As per Section 188 40 Crore 2026-2027
Services Private the Company and RPT policy of the
Limited Company
3. Kaushal Uttam Shah Promoter of As per Section 188 40 Crore 2026-2027
the Company and RPT policy of the
Company
4. GTT Data Solutions The company As per Section 188 40 Crore 2026-2027
Limited belongs to and RPT policy of the
same Company
Promoter
Group
5. SMCV The company As per Section 188 50 Crore 2026-2027
Management belongs to and RPT policy of
Services Private same the Company
Limited Promoter
Group
6 Tec-Pool Solutions Wholly As per Section 188 40 Crore 2026-2027
Private Limited owned and RPT policy of
Subsidiary the Company
7 Health Secure Wholly As per Section 188 40 Crore 2026-2027
Hospitals Private owned and RPT policy of
Limited Subsidiary the Company
8 Arvaya Healthtech Wholly As per Section 188 40 Crore 2026-2027
& Wellness Private owned and RPT policy of
Limited Subsidiary the Company
9 Sushodha Institute Related Party As per Section 188 40 Crore 2026-2027
of and RPT policy of
Gastroenterology the Company
Private Limited
RESOLVED FURTHER THAT the Board of Directors (Including any committee thereof) or Chief Financial
Officer or officials (powers conferred by authority letter or Power of Attorney) of the company be and
are hereby authorized to do all such acts, deeds, matters and things as it may deem fit at its absolute
discretion and to take all such steps as may be required in this connection including finalizing and
executing necessary documents, contract(s), scheme(s), agreement(s) and such other documents as
may be required, seeking all necessary approvals to give effect to this resolution, for and on behalf of
the Company
[Showing first 8,000 characters — download PDF for full document]